A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.
- DOI
- 10.3389/fimmu.2026.1802339
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1802339,
title = {A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.},
author = {Miguela A and Huertas-Pons JM and Coll-Martinez C and Gifreu-Fraixinó A and Salavedra-Pont J and Comabella M and Villar LM and Gich J and Álvarez-Bravo G and Ramió-Torrentà L and Quiroga-Varela A},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1802339},
url = {https://doi.org/10.3389/fimmu.2026.1802339}
}RIS
TY - JOUR TI - A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline. AU - Miguela A AU - Huertas-Pons JM AU - Coll-Martinez C AU - Gifreu-Fraixinó A AU - Salavedra-Pont J AU - Comabella M AU - Villar LM AU - Gich J AU - Álvarez-Bravo G AU - Ramió-Torrentà L AU - Quiroga-Varela A PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1802339 UR - https://doi.org/10.3389/fimmu.2026.1802339 ER -
APA
A, M., JM, H., C, C., A, G., J, S., M, C., LM, V., J, G., G, Á., L, R., & A, Q. (2026). A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1802339
Source records
- pubmed · retrieved 2026-09-27T12:26:04.611Z
- europe-pmc · retrieved 2026-09-27T12:26:04.628Z
- doaj · retrieved 2026-09-27T12:26:04.622Z